Valproic Acid Capsule
Product Images NDC 0832-0310

4 FDA label images from Upsher-smith Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 0832-0310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Valproic 01)

Chemical Structure (Valproic 01)
Chemical structure of valproic acid, showing its carbon chain and carboxylic acid functional group depicted as CH3-CH2-CH2 attached to a central carbon linked to a carboxyl group (C=O and OH).*
FDA Label Image

Figure 1 (Valproic 02)

Figure 1 (Valproic 02)
A line graph comparing the percentage reduction in CPS rate between patients treated with divalproex sodium and placebo. The x-axis represents the percentage of patients, while the y-axis shows the percentage reduction in CPS rate, ranging from -100% (worsening) to 100% (improvement). The solid line represents divalproex sodium, and the dashed line represents placebo.*
FDA Label Image

Figure 2 (Valproic 03)

Figure 2 (Valproic 03)
A line graph showing the percentage reduction in CPS rate versus percent of patients for valproic acid capsules. Two lines represent high dose (solid line) and low dose (dashed line). The vertical axis indicates percent reduction ranging from -100% (worsening) to 100% (improvement), and the horizontal axis shows percent of patients from 100% to 0%. The graph illustrates the distribution of patient responses to high and low doses.*
FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Principal Display Panel (250 mg Capsule Bottle Label)
Label for Valproic Acid Capsules, USP 250 mg by Upsher-Smith Laboratories, LLC. The label indicates 100 capsules per bottle for oral use, prescription only. It includes dosage strength, manufacturer information, medication guide instruction for pharmacists, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.